# 藥動
## 給藥 Administration
- 通常口服
## 分布 Distribution
- 分布於身體各處
- 穿透腦脊髓液(CSF)和胎盤屏障(placental barrier)
- 高血漿蛋白親和性(取代性)
## 代謝 Metabolism
- N<sup>4</sup>-[[Acetylation and Amino acid conjugation|acetylation]]
	- 在肝臟進行
	- 造成結晶尿(crystalluria)
- [[Oxidative reactions​|Hydroxylation]] of benzene ring
- [[Oxidative reactions​|Hydroxylation]] of heterocycle ring
- Form [[Glucuronic acid (GA) conjugation|O-glucuronide]]
## 排泄 Excretion
- 腎絲球過濾排除
# 應用
## ⚡急性泌尿道感染(UTIs)
- [[sulfisoxazole]], [[co-trimoxazole]]
## 土壤絲菌病(Nocardiosis)
- [[sulfisoxazole]], [[Silver sulfadiazine|sulfadiazine]], or [[tetracycline]]
## 外用 (Topical uses)
- [[sulfacetamide]], [[silver sulfadiazine]], [[Mafenide acetate (sulfamylon)|mafenide]]
## 細菌性結膜炎(bacterial conjunctivitis)
- [[sulfacetamide]], or [[tetracycline]]
## 急性中耳炎(Acute otitis media)
- [[sulfisoxazole]]
## 特殊用途
- ⚡**瘧疾[[malaria]]**: [[sulfasalazine]], sulfadoxine
- **毒漿體原蟲病toxoplasmosis**: [[Silver sulfadiazine|sulfadiazine]]
# 副作用
## ⚡晶尿症(Crystalluria)
- [[sulfisoxazole]], [[sulfamethoxazole]]
## ⚡溶血性貧血
- G6PD
## ⚡核黃疸(Kernicterus)
- 新生兒
## 加強其他藥物
- tolbutamide, [[Dicumarol and Warfarin|warfarin]], [[Methotrexate (MTX)|methotrexate]]
## [[過敏反應 hypersensitivity|過敏]]([[過敏反應 hypersensitivity|Hypersensitivity]])
- 紅疹, 血管性水腫(angioedema), [[Stevens-Johnson syndrome|SJS]]
# 抗藥性
- alter dihydropteroate synthetase 
- 降低細胞膜穿透率
- 增加 PABA 合成
# 藥化
## MOA
- 可逆競爭型抑制劑
- 抑制葉酸合成
	- 抑制 dihydropteroate synthetase
- [[Bacteriostatic and bactericidal|Bacteriostatic]]
- false metabolite
## SAR
- ![[Pasted image 20230314095604.png]]
### 必須
- Primary amino group
- Aromatic ring
- *para*-Substitution
- [[Sulfonamide class|Sulfonamide]] group
- [[Sulfonamide class|Sulfonamide]] nitrogen 一級或二級
- [[Sulfonamide class|sulfonamide]] nitrogen 上的 H pKa 與 PABA 相似(~ 6.5)
- aromatic ring 無其他取代
